Updated:
Munich Medical International
Prof. Dr. Frank Christ chairs Munich Medical International, an LMU-spun asset manager developing healthcare-anchored real assets across Europe and Russia.
Munich Medical International
Munich Medical International originated as a commercial venture linked to Ludwig-Maximilians-Universität München (LMU), one of Germany's leading research universities. Prof. Dr. Frank Christ, Chairman and Managing Partner, led the firm's establishment to bridge clinical research and medical infrastructure investment. The firm operates from Zurich, reflecting a Swiss corporate base while deploying capital into specialised healthcare property assets across continental Europe and Russia. MMI's strategy centres on developing and managing large-scale medical facilities. Its portfolio spans hospital complexes, clinical centres, and mixed-use medical properties. Known assets include the Moscow Clinical Scientific Center, a major healthcare facility in the Russian capital, and the Narva Triumphal Arch Medical Center, a mixed-use redevelopment in St. Petersburg. The firm also held investment exposure to the Anapa Military Hospital project. Co-investment structures feature prominently: MMI partnered with TVM Capital Healthcare, a specialist healthcare private equity firm, as a strategic investor in the TVM Healthcare MENA I fund, which targets healthcare delivery assets in the Middle East and North Africa. The leadership team marries medical and financial disciplines. Prof. Christ anchors the clinical and academic connection to LMU, while Managing Partner Rolf Engel, also founder of International Campus GmbH, brings operational expertise in large-scale residential and healthcare property development. No public headcount or total AUM exists. The firm manages discrete assets and fund commitments rather than a reported consolidated pool of capital. MMI's identity is structurally distinct from standard healthcare private equity. It is neither a blind-pool fund manager raising third-party capital nor a single-family office. It operates as a project-specific asset developer and co-investor, originating deals from academic medical networks and matching them with property development execution teams. The connection to LMU gives it a clinical sourcing channel that commercial developers cannot easily replicate. Its Swiss domicile offers jurisdictional neutrality for cross-border healthcare infrastructure projects, particularly those involving complex regulatory environments in Russia and the CIS.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Zurich
Corporate office
Zurich, Switzerland
Principals
Prof. Dr. Frank Christ
Chairman and Managing Partner
Rolf Engel
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Munich Medical International?
Prof. Dr. Frank Christ chairs the firm and serves as Managing Partner alongside Rolf Engel. Christ provides the clinical and academic underwriting grounded in LMU's medical research network. Engel's background in property development through International Campus GmbH suggests he leads real estate structuring and project execution. The partnership structure points to joint decision-making on new asset commitments.
How does Munich Medical International source its healthcare infrastructure deals?
MMI's origination model ties directly to Ludwig-Maximilians-Universität München. As an LMU spin-off, the firm accesses clinical networks, academic medical research departments, and hospital relationships that identify gaps in healthcare infrastructure. This relationship-based sourcing differentiates it from purely financial healthcare investors. Specific assets in Moscow and St. Petersburg indicate sourcing capability in Russian-language markets.
Does Munich Medical International raise external funds, or is it balance-sheet capital?
MMI's capital structure is not publicly detailed. It appears to develop assets on a project-specific basis rather than through traditional blind-pool fund structures. The firm's participation as a strategic partner in TVM Capital Healthcare's MENA I fund shows it co-invests alongside external managers. Whether MMI contributes balance-sheet capital or represents co-investors is not disclosed.
What is the relationship between Munich Medical International and TVM Capital Healthcare?
MMI is cited as a strategic partner and co-investor in the TVM Healthcare MENA I fund, a specialist vehicle targeting healthcare delivery and service investments in the Middle East and North Africa. The partnership marries TVM's emerging-market healthcare private equity expertise with MMI's European clinical and academic networks. Their co-investment model gives MMI exposure to healthcare assets beyond its direct Russian and European property portfolio.
What geographies does Munich Medical International invest in?
The firm's known assets concentrate in Russia: the Moscow Clinical Scientific Center, the Narva Triumphal Arch Medical Center in St. Petersburg, and the Anapa Military Hospital project on the Black Sea coast. Through the TVM Healthcare MENA I partnership, MMI also has exposure to Middle Eastern and North African healthcare delivery investments. The Zurich headquarters suggests a European deal-sourcing and structuring base.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: